Beta-blocker therapy cuts all-cause mortality in STEMI
(HealthDay)—For patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI), beta-blocker therapy at discharge correlates with reduced all-cause mortality, ...
Jun 18, 2014
0
0